Angiotensin II receptor blockade in diabetic nephropathy

被引:19
作者
Ruddy, MC [1 ]
机构
[1] Med Ctr Princeton, Nephrol Sect, Princeton, NJ USA
关键词
D O I
10.1016/S0895-7061(01)02320-2
中图分类号
R6 [外科学];
学科分类号
1002 [临床医学]; 100210 [外科学];
摘要
引用
收藏
页码:468 / 471
页数:4
相关论文
共 23 条
[1]
ASSOCIATION OF THE RENIN SODIUM PROFILE WITH THE RISK OF MYOCARDIAL-INFARCTION IN PATIENTS WITH HYPERTENSION [J].
ALDERMAN, MH ;
MADHAVAN, S ;
OOI, WL ;
COHEN, H ;
SEALEY, JE ;
LARAGH, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (16) :1098-1104
[2]
Preserving renal function in adults with hypertension and diabetes: A consensus approach [J].
Bakris, GL ;
Williams, M ;
Dworkin, L ;
Elliott, WJ ;
Epstein, M ;
Toto, R ;
Tuttle, K ;
Douglas, J ;
Hsueh, W ;
Sowers, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03) :646-661
[3]
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[4]
ESSENTIAL HYPERTENSION - RENIN AND ALDOSTERONE, HEART ATTACK AND STROKE [J].
BRUNNER, HR ;
BUHLER, FR ;
BARD, RH ;
BAER, L ;
GOODWIN, FT ;
NEWTON, MA ;
KRAKOFF, LR ;
LARAGH, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 286 (09) :441-+
[5]
RENIN - RISK FACTOR FOR CARDIOVASCULAR-DISEASE [J].
CHRISTLIEB, AR ;
GLEASON, RE ;
HICKLER, RB ;
LAULER, DP .
ANNALS OF INTERNAL MEDICINE, 1974, 81 (01) :7-10
[6]
DEINUM J, 2000, HYPERTENSION COMPANI, P70
[7]
The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors [J].
Golan, L ;
Birkmeyer, JD ;
Welch, HG .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (09) :660-+
[8]
Diabetes and cardiovascular disease - A statement for healthcare professionals from the American Heart Association [J].
Grundy, SM ;
Benjamin, IJ ;
Burke, GL ;
Chait, A ;
Eckel, RH ;
Howard, BV ;
Mitch, W ;
Smith, SC ;
Sowers, JR .
CIRCULATION, 1999, 100 (10) :1134-1146
[9]
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:: principal results of the hypertension optimal treatment (HOT) randomised trial [J].
Hansson, L ;
Zanchetti, A ;
Carruthers, SG ;
Dahlöf, B ;
Elmfeldt, D ;
Julius, S ;
Ménard, J ;
Rahn, KH ;
Wedel, H ;
Westerling, S .
LANCET, 1998, 351 (9118) :1755-1762
[10]
Pathways for angiotensin II generation in intact human tissue - Evidence from comparative pharmacological interruption of the renin system [J].
Hollenberg, NK ;
Fisher, NDL ;
Price, DA .
HYPERTENSION, 1998, 32 (03) :387-392